Sreedhar Sappidi – Daicel Chiral Technologies (India) Pvt Ltd
View Detailed Executive Profile →Professional Overview
- Sreedhar Sappidi founded NEXST Cell and Analytical Solutions Pvt Ltd, taking on the role of Founder and Director starting August 1, 2023, indicating a strong entrepreneurial initiative in the biotechnology sector.
- Previously served as Director of Peptides & Biologics at Daicel Chiral Technologies India Pvt Ltd from April 2021 until August 2023, overseeing critical operations and strategic developments in the peptides and biologics segment.
- Held the position of Associate Director for Biologics at Daicel Chiral Technologies India Pvt Ltd from December 2019 to April 2021, contributing significantly to advancements in biologics through innovative strategies and leadership.
- In a prior role as Senior Manager & Head of Biopharma at Vimta Labs Ltd from August 2015 to November 2019, was responsible for managing biopharmaceutical projects and leading research initiatives that enhanced the company’s service offerings.
- Also worked as Team Lead for Analytical R&D at Nagarjuna Innovation Centre from May 2014 to July 2015, where the focus was on developing analytical methods and methodologies to support R&D projects.
- Served as Manager of Analytical Development at Zenotech Laboratories from February 2012 to March 2014, leading efforts in analytical method development that contributed to the company's product development pipelines.
- Worked as a Consultant in Biotech at Virchow Biotech from October 2010 to October 2011, providing expert advice on biotechnology projects and helping navigate challenges in biopharmaceutical development.
- Commenced career at Intas Pharmaceuticals Limited as Scientist in Biocharacterization from April 2004 to August 2010, focusing on biocharacterization techniques that are essential for the development of biopharmaceutical products.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Virchow Biotech | Consultant-Biotech | Oct 2010 – Oct 2011 |
| Nagarjuna Innovation Centre | Team Lead _Analytical R&D | May 2014 – Jul 2015 |
| Zenotech Laboratories Limited (Hyderabad) | Manager- Analytical Development | Feb 2012 – Apr 2014 |
| DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LIMITED | Associate Director- Biologics | Dec 2019 – Apr 2021 |
| Vimta Labs Ltd | Senior Manager & Head, Biopharma | Aug 2015 – Nov 2019 |
| DAICEL CHIRAL TECHNOLOGIES INDIA PRIVATE LIMITED | Director- Peptides & Biologics | Apr 2021 – Aug 2023 |
| Intas Pharmaceticals Limited | Scientist- Biocharacterization | Apr 2004 – Aug 2010 |
| NEXST Cell and Analytical Solutions Pvt Ltd | Founder and Director | Aug 2023 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Daicel Chiral Technologies (India) Pvt Ltd corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Sreedhar Sappidi's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Daicel Chiral Technologies (India) Pvt Ltd's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)